Where AI is accelerating across health and science
A 19-month comparison separates AI supply across clinical diagnostics, drug discovery, biology, patient operations, materials, mathematics, and autonomous science.
Health and science AI is fragmenting into markets with different formation speeds
The measured health-and-science supply index changed +61.9% between Q1 2025 and May–July 2026. Autonomous scientific discovery accelerated fastest (+345.5%), while clinical diagnostics & imaging remained the largest observed body of work. The category is not moving as a single market.
01
Market snapshot
Comparable measurements from independent market surfaces.
12,140
domain observations
Direction-level arXiv matches plus retained GitHub and Product Hunt items.
11,215
arXiv direction matches
Complete counts from 133 monthly direction queries; a paper may match more than one direction.
924
open-source implementations
Retained from 924 inspected GitHub repositories.
+61.9%
composite supply change
Q1 2025 compared with May–July 2026.
02
Research, implementation, and product supply
Each source is indexed independently; the Q1 2025 monthly average equals 100.
Drug discovery & molecular design900 papers · 54 repos · 0 products (excluded: small sample)
+18.9%
04
What is changing beneath the headline growth
Structural findings that a single aggregate number would hide.
+345.5%
Autonomous scientific discovery is accelerating fastest
The result reflects relative change inside comparable source cohorts, not the absolute size of the clinical or scientific market.
3997
Clinical diagnostics & imaging remains the largest measured direction
Scale and growth are different signals: the largest body of work is not necessarily the fastest-forming product category.
0/7
Commercial visibility still trails scientific specialization
Only directions with at least 30 retained Product Hunt launches use product data in their composite index. Thin product samples remain visible rather than being treated as zero demand.
